China’s biotech industry is rapidly moving up the value chain, prompting fears in the US and calls for tighter controls.

The biotech industry has pushed the boundaries of human health and scientific understanding for decades. But a new revolution is brewing—not in the lab, but in the supply chain. By embracing ...

Over the last few years, Supriya Life Sciences has expanded beyond its traditional API business. By targeting markets ...

Scientific breakthroughs will enable a future of personalized drug discovery, where precision medicine makes it possible to receive the right dose of the right medicine at the right time. America’s ...

Collaborations structured across three strategic clusters, supporting Globalpharma’s efforts to strengthen capabilities ...

By IntelliNews The international pharmaceutical industry relies on a model of globalised production and value chains to ...

Two pillars are key in this supply chain to ensure the product is getting safely to the consumer: traceability and security.

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Biotech firms use AI in trials to target patients more ...

Global High Potency API CDMOs Market OverviewThe global high potency active pharmaceutical ingredient (HPAPI) CDMOs market is ...